Cardiovascular Systems Inc (OQ:CSII)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 1225 Old Highway 8 NW
ST. PAUL MN 55112-6416
Tel: 1-651-2024919
IR: See website
Key People
Scott R. Ward
Chairman of the Board, President, Chief Executive Officer
Jeffrey S. Points
Chief Financial Officer
Rhonda J. Robb
Chief Operating Officer
Sandra Marie Sedo
Chief Compliance Officer
John M. Hastings
Vice President of Manufacturing and Operations
David S. Whitescarver
Vice President of Corporate Development and Intellectual Property
Alexander Rosenstein
General Counsel and Corporate Secretary
Ryan D. Egeland
Chief Medical Officer
Laura J. Gillund
Chief Talent Officer
Business Overview
Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.
Financial Overview
For the fiscal year ended 30 June 2020, Cardiovascular Systems Inc revenues decreased 5% to $236.5M. Net loss increased from $255K to $27.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.01 to -$0.79.
Employees: 731 as of Jun 30, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $1,012M as of Jun 30, 2020
Annual revenue (TTM): $236.55M as of Jun 30, 2020
EBITDA (TTM): -$22.59M as of Jun 30, 2020
Net annual income (TTM): -$27.24M as of Jun 30, 2020
Free cash flow (TTM): N/A
Net Debt Last Fiscal Year: N/A
Shares outstanding: 39,502,420 as of Jun 30, 2020
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.